Market Tracker

03/24 5:16pm ET

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

1.12
Delayed Data
As of Mar 24
 -0.02 / -1.75%
Today’s Change
0.26
Today|||52-Week Range
1.51
+151.69%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close1.14
Today’s open1.16
Day’s range1.11 - 1.17
Volume1,393,233
Average volume (3 months)3,528,313
Market cap$139.0M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-251.54%
Earnings growth (this year)+24.14%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+110.79%
P/E ratioNM
Price/Sales4.90
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EVGNEvogene Ltd+0.04+0.77%
PFNXPfenex Inc0.000.00%
QUREUniqure NV+0.13+2.29%
NVIVInVivo Therapeutics ...-0.05-1.23%
Data as of 4:02pm ET, 03/24/2017

Financials

Last reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$9.2M
Annual profit (last year)-$29.4M
Net profit margin-317.16%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Moshe Manor
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, Haifa

Forecasts